Breaking News Instant updates and real-time market news.

CPRX

Catalyst Pharmaceuticals

$3.20

0.06 (1.91%)

11:03
05/13/19
05/13
11:03
05/13/19
11:03

Piper says Catalyst's 'impressive' Firdapse sales clouded by Jacobus uncertainty

Piper Jaffray analyst Joseph Catanzaro raised his 2019 Firdapse estimates after the "impressive" results reported by Catalyst Pharmaceuticals in the first quarter of sales for the drug, but he also noted that the recent unexpected approval of Jacobus' Ruzurgi for the treatment of pediatric patients with LEMS puts his Firdapse estimates at risk. While acknowledging the potential implications of a Ruzurgi launch, the analyst raised his FY19 Firdapse sales estimate to $72.5M from $41.0M. Catalyst management said they expects Firdapse revenue to "substantially increase" in Q2 over Q1, but would not give 2019 guidance due to last week's news about Ruzurgi, noted Catanzaro, who keeps an Overweight rating and $7.50 price target on Catalyst shares.

  • 13

    May

  • 23

    May

CPRX Catalyst Pharmaceuticals
$3.20

0.06 (1.91%)

03/19/19
PIPR
03/19/19
NO CHANGE
Target $7.5
PIPR
Overweight
Catalyst comments point toward strong Firdapse launch, says Piper Jaffray
Shares of Catalyst Pharmaceuticals are trading higher after the company's Q4 earnings call and comments from management that point toward a strong Firdapse launch, Piper Jaffray analyst Joseph Catanzaro tells investors in a research note. Accrual of former EAP patients onto Catalyst Pathways has been quicker than expected and payer interactions appear to be progressing nicely, adds the analyst. He views his $41.0M 2019 sales estimate as "readily achievable" and maintains an Overweight rating on Catalyst Pharmaceuticals with a $7.50 price target.
03/19/19
HCWC
03/19/19
NO CHANGE
HCWC
Catalyst's initial launch of Firdapse 'strong,' says H.C. Wainwright
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating and $9 price target on Catalyst Pharmaceuticals, saying the initial look at the Firdapse commercial launch suggests "healthy momentum" and "strong execution" on the part of the company. The analyst also noted that Firdapse is also being investigated in two Phase 3 trials for the treatment of anti-MuSK antibody positive myasthenia gravis and congenital myasthenic syndromes, with both trials planned to read out in the second half of 2019.
05/06/19
PIPR
05/06/19
NO CHANGE
Target $7.5
PIPR
Overweight
Ruzurgi approval to pressure Catalyst Pharmaceuticals, says Piper Jaffray
Piper Jaffray analyst Joseph Catanzaro kept his Overweight rating and $7.50 price target on Catalyst Pharmaceuticals but warned that the stock could come under pressure after the FDA's "unexpected" approval of Jacobus' amifampridine, or Ruzurgi, for the treatment of pediatric LEMS patients. Shares of Catalyst Pharmaceuticals were down over 41% after hours, and the analyst expressed uncertainty over whether the company's Firdapse would be able to maintain the orphan drug price point set at launch. Catanzaro expects the management of Catalyst Pharmaceuticals to comment on the development.
05/07/19
CANT
05/07/19
NO CHANGE
Target $10
CANT
Overweight
Jacobus approval should not impact Catalyst's Firdapse, says Cantor Fitzgerald
The FDA last night approved private company Jacobus' Ruzurgi for the treatment of Lambert-Eaton myasthenic syndrome in patients six to less than 17 years of age, Cantor Fitzgerald analyst Charles Duncan tells investors in a research note. This is the first drug approved for pediatric LEMS, the analyst points out. Catalyst Pharmaceuticals' slightly different salt form of amifampridine, marketed as Firdapse, was the first drug approved for LEMS, but for adults only, he notes. The analyst does not see the approval of Ruzurgi as having a large impact in Firdapse's market potential. He estimates that the pediatric population consists of less than 5% of the prevalent LEMS population. Duncan reiterates an Overweight rating on Catalyst shares with a $10 price target.

TODAY'S FREE FLY STORIES

SHAK

Shake Shack

$100.80

0.8 (0.80%)

05:09
09/17/19
09/17
05:09
09/17/19
05:09
Recommendations
Shake Shack analyst commentary  »

Shake Shack price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$14.10

0.33 (2.40%)

05:09
09/17/19
09/17
05:09
09/17/19
05:09
Recommendations
Momenta analyst commentary  »

Momenta risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

SEAS

SeaWorld

$30.09

-0.01 (-0.03%)

04:59
09/17/19
09/17
04:59
09/17/19
04:59
Recommendations
SeaWorld analyst commentary  »

SeaWorld selloff on CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$101.76

4.35 (4.47%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Ligand management to meet with Craig-Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 20

    Sep

  • 02

    Oct

  • 13

    Nov

SGC

Superior Uniform

$16.39

-0.21 (-1.27%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Superior Uniform management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

UCBI

United Community Banks

$27.93

-0.115 (-0.41%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
United Community Banks management to meet with Sandler ONeill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 13

    Nov

04:55
09/17/19
09/17
04:55
09/17/19
04:55
General news
Industrial Production Capacity Utilization Rate to be reported at 09:15 »

August Industrial…

TRIP

TripAdvisor

$41.14

0.35 (0.86%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
TripAdvisor management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

V

Visa

$176.12

-1.16 (-0.65%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Visa management to meet with Evercore ISI »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 23

    Sep

  • 27

    Oct

EQIX

Equinix

$550.00

13.42 (2.50%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Equinix management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 16

    Dec

WIRE

Encore Wire

$60.43

0.55 (0.92%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Encore Wire management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

04:55
09/17/19
09/17
04:55
09/17/19
04:55
General news
Industrial Production to be reported at 09:15 »

August Industrial…

TNXP

Tonix Pharmaceuticals

$0.49

0.0136 (2.89%)

, NEPH

Nephros

$7.59

(0.00%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Microcap to hold a summit »

Fall Investor Summit 2019…

TNXP

Tonix Pharmaceuticals

$0.49

0.0136 (2.89%)

NEPH

Nephros

$7.59

(0.00%)

RESN

Resonant

$3.07

0.03 (0.99%)

ZOM

Zomedica

$0.42

-0.0313 (-6.96%)

MYSZ

MySize

$0.49

0.0186 (3.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

  • 12

    Nov

CTLT

Catalent

$50.62

-0.71 (-1.38%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Catalent management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

JAZZ

Jazz Pharmaceuticals

$133.80

2.35 (1.79%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Jazz Pharmaceuticals management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

CDK

CDK Global

$46.88

0.61 (1.32%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
CDK Global management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

AMED

Amedisys

$130.73

-2.13 (-1.60%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Amedisys management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 13

    Nov

AB

AllianceBernstein

$29.68

0.08 (0.27%)

, AFIN

American Finance Trust

$13.60

0.24 (1.80%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
NAREIT to hold a forum »

NAREIT SFO Forum 2019…

AB

AllianceBernstein

$29.68

0.08 (0.27%)

AFIN

American Finance Trust

$13.60

0.24 (1.80%)

AMT

American Tower

$216.74

1.455 (0.68%)

BXP

Boston Properties

$132.04

0.5 (0.38%)

C

Citi

$69.83

-0.54 (-0.77%)

COF

Capital One

$94.39

0.79 (0.84%)

CXP

Columbia Property

$21.41

0.04 (0.19%)

DUK

Duke Energy

$93.13

-0.83 (-0.88%)

HST

Host Hotels

$17.40

0.07 (0.40%)

KIM

Kimco Realty

$20.00

-0.13 (-0.65%)

KRC

Kilroy Realty

$76.98

1.02 (1.34%)

MFG

Mizuho Financial Group

$3.12

-0.04 (-1.27%)

PLD

Prologis

$85.28

1.065 (1.26%)

REG

Regency Centers

$68.26

0.16 (0.23%)

RPAI

Retail Properties of America

$11.96

0.04 (0.34%)

SLG

SL Green Realty

$81.96

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 19

    Sep

  • 25

    Sep

  • 26

    Sep

  • 02

    Oct

  • 15

    Oct

  • 24

    Oct

  • 27

    Oct

  • 30

    Oct

  • 31

    Oct

  • 10

    Nov

  • 10

    Nov

FMC

FMC Corporation

$91.02

-0.025 (-0.03%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
FMC Corporation management to meet with Stephens »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 30

    Oct

ORA

Ormat Technologies

$71.94

-0.27 (-0.37%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Ormat Technologies management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

TITN

Titan Machinery

$15.19

0.11 (0.73%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Titan Machinery management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 13

    Nov

VST

Vistra Energy

$26.57

0.32 (1.22%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Vistra Energy management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 02

    Oct

CME

CME Group

$207.01

1.26 (0.61%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
CME Group management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Morgan Stanley steel analyst to hold an analyst/industry conference call »

China Materials Analyst…

CYCN

Cyclerion Therapeutics

$12.35

1.17 (10.47%)

04:55
09/17/19
09/17
04:55
09/17/19
04:55
Conference/Events
Cyclerion Therapeutics to hold an investor event »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.